Moleculin Biotech (MBRX) EPS (2016 - 2026)
Moleculin Biotech (MBRX) EPS from Mar 31, 2016 to Mar 31, 2026. The TTM Moleculin Biotech (MBRX) EPS is -$25.11. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Moleculin Biotech (MBRX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.80% |
| 3 Years TTM | -10.41% |
| 5 Years TTM | -23.05% |
| 10 Years TTM | +3.26% |
| All Time TTM | -15.94% |
Annual EPS change of Moleculin Biotech (MBRX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$2.41 | -77.06% |
| 2025 | -$10.49 | -33.15% |
| 2024 | -$15.69 | -4.34% |
| 2023 | -$16.40 | -62.08% |
| 2022 | -$43.26 | +24.33% |
| 2021 | -$34.80 | -62.11% |
| 2020 | -$91.83 | -22.97% |
| 2019 | -$119.21 | -27.59% |
| 2018 | -$164.63 | -7.45% |
| 2017 | -$177.89 | +35.72% |
| 2016 | -$131.07 | N/A |
Comparison Moleculin Biotech (MBRX) five years EPS CAGR with competitors
Moleculin Biotech (MBRX) five years EPS CAGR is -27.22%.